The effect of aerosolized and intravenously administered clenbuterol and aerosolized fluticasone propionate on horses challenged with Aspergillus fumigatus antigen

Veterinary Research Communications

Volumn 30, Issue 6, 2006, Pages 623-635

  Laan, T T J M ^a   Bull, S ^a,b   van Nieuwstadt, R A ^a   Fink Gremmels, J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Alveolar macrophages; Anti inflammatory; Clenbuterol; Fluticasone propionate; Recurrent airway obstruction (RAO)

Indexed keywords

BETA ACTIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; CYTOKINE; FLUTICASONE PROPIONATE; FUNGUS ANTIGEN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

AEROSOL; AIRWAY OBSTRUCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CELL COUNT; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXPERIMENTAL MODEL; HORSE; INHIBITION KINETICS; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LYMPHOCYTE COUNT; MACROPHAGE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROVOCATION TEST; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ANDROSTADIENES; ANIMALS; ANTIGENS, FUNGAL; ASPERGILLUS FUMIGATUS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHODILATOR AGENTS; CLENBUTEROL; CYTOKINES; FEMALE; HORSE DISEASES; HORSES; INJECTIONS, INTRAVENOUS; LUNG DISEASES, OBSTRUCTIVE; MACROPHAGES, ALVEOLAR; RANDOM ALLOCATION; TREATMENT OUTCOME;

ASPERGILLUS FUMIGATUS; EQUIDAE;

EID: 33745935971     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11259-006-3346-9     Document Type: Article

References (41)

1. Abraham, G., Brodde, O.E. and Ungemach, F.R., 2002. Regulation of equine lymphocyte beta-adrenoceptors under the influence of clenbuterol and dexamethasone. Equine Veterinary Journal, 34, 587-593
2. Ainsworth, D.M., Grunig, G., Matychak, M.B., Young, J., Wagner, B., Erb, H.N. and Antczak, D.F., 2003. Recurrent airway obstruction (RAO) in horses is characterized by IFN-gamma and IL-8 production in bronchoalveolar lavage cells. Veterinary Immunology and Immunopathology, 96, 83-91
3. Barnes, P.J., Ito, K. and Adcock, I.M., 2004. Corticosteroid resistance in chronic obstructive pulmonary disease: Inactivation of histone deacetylase. Lancet, 363, 731-733
4. Dixon, P.M., Railton, D.I., McGorum, B.C. and Tothill, S., 1995. Equine pulmonary disease: A case control study of 300 referred cases. Part 4: Treatments and re-examination findings. Equine Veterinary Journal, 27, 436-439
5. Farmer, P. and Pugin, J., 2000. β-Adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IκB/NF-κB pathway. American Journal of Physiology. Lung Cellular and Molecular Physiology, 279, L675-682
6. Fernandez, S., Jose, P., Avdiushko, M.G., Kaplan, A.M. and Cohen, D.A., 2004. Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists. Journal of Immunology, 172, 2613-2620
7. Franchini, M., Gilli, U., Akens, M.K., Fellenberg, R.V. and Bracher, V., 1998. The role of neutrophil chemotactic cytokines in the pathogenesis of equine chronic obstructive pulmonary disease (COPD). Veterinary Immunology and Immunopathology, 66, 53-65
8. Giguere, S., Viel, L., Lee, E., MacKay, R.J., Hernandez, J. and Franchini, M., 2002. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate. Veterinary Immunology and Immunopathology, 85, 147-158
9. Gizycki, M.J., Hattotuwa, K.L., Barnes, N. and Jeffery, P.K., 2002. Effects of fluticasone propionate on inflammatory cells in COPD: An ultrastructural examination of endobronchial biopsy tissue. Thorax, 57, 799-803
10. Harding, S.M., 1990. The human pharmacology of fluticasone propionate. Respiratory Medicine, 84 (supplement A), 25-29
11. Hattotuwa, K.L., Gizycki, M.J., Ansari, T.W., Jeffery, P.K. and Barnes, N.C., 2002. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: A double-blind, placebo-controlled biopsy study. American Journal of Respiratory and Critical Care Medicine, 165, 1592-1596
12. Izeboud, C.A., Mocking, J.A., Monshouwer, M., van Miert, A.S. and Witkamp, R.F., 1999a. Participation of beta-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. Journal of Receptor and Signal Transduction Research, 19, 191-202
13. Izeboud, C.A., Monshouwer, M., van Miert, A.S. and Witkamp, R.F., 1999b. The beta-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-alpha and IL-6 in vitro and in vivo. Inflammation Research, 48, 497-502
14. Izeboud, C.A., Hoebe, K.H., Grootendorst, A.F., Nijmeijer, S.M., van Miert, A.S., Witkamp, R.R. and Rodenburg, R.J., 2004. Endotoxin-induced liver damage in rats is minimized by beta 2-adrenoceptor stimulation. Inflammation Research, 53, 93-99
15. Jeffery, P.K., Venge, P., Gizycki, M.J., Egerod, I., Dahl, R. and Faurschou, P., 2002. Effects of salmeterol on mucosal inflammation in asthma: A placebo-controlled study. European Respiratory Journal, 20, 1378-1385
16. Johnson, M., 2002. Effects of beta2-agonists on resident and infiltrating inflammatory cells. Journal of Allergy and Clinical Immunology, 110, S282-290
17. Laan, T.T., Westermann, C.M., Dijkstra, A.V., van Nieuwstadt, R.A. and Fink-Gremmels, J., 2004. Biological availability of inhaled fluticasone propionate in horses. Veterinary Record, 155, 361-364
18. new Laan, T.T.J.M., Bull, S., Pirie, R.S. and Fink-Gremmels, J., 2006. Macrophages in the pathogenesis of recurrent airway obstruction in horses. Journal of Veterinary Internal Medicine, 20, 167-174
19. Lavoie, J.P., Maghni, K., Desnoyers, M., Taha, R., Martin, J.G. and Hamid, Q.A., 2001. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. American Journal of Respiratory and Critical Care Medicine, 164, 1410-1413
20. Lentsch, A.B., Czermak, B.J., Bless, N.M., Van Rooijen, N. and Ward, P.A., 1999. Essential role of alveolar macrophages in intrapulmonary activation of NF-κB. American Journal of Respiratory Cell and Molecular Biology, 20, 692-698
21. Libert, C., Takahashi, N., Cauwels, A., Brouckaert, P., Bluethmann, H. and Fiers, W., 1994. Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality. European Journal of Immunology, 24, 2237-2242
22. Lien, E. and Ingalls, R.R., 2002. Toll-like receptors. Critical Care Medicine, 30, S1-11.
23. Mair, T.S. and Derksen, F.J., 2000. Chronic obstructive pulmonary disease: A review. Equine Veterinary Education, 12, 35-44
24. Marr, K.A., Balajee, S.A., Hawn, T.R., Ozinsky, A., Pham, U., Akira, S., Aderem, A. and Liles, W.C., 2003. Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infectious Immunology, 71, 5280-5286
25. McGorum, B.C., Dixon, P.M. and Halliwell, R.E., 1993a. Responses of horses affected with chronic obstructive pulmonary disease to inhalation challenges with mould antigens. Equine Veterinary Journal, 25, 261-267
26. McGorum, B.C., Dixon, P.M., Halliwell, R.E. and Irving, P., 1993b. Evaluation of urea and albumen as endogenous markers of dilution of equine bronchoalveolar lavage fluid. Research in Veterinary Science, 55, 52-56
27. Meier, A., Kirschning, C.J., Nikolaus, T., Wagner, H., Heesemann, J. and Ebel, F., 2003. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus -induced activation of murine macrophages. Cellular Microbiology, 5, 561-570
28. Nakamura, A., Imaizumi, A., Kohsaka, T., Yanagawa, Y. and Johns, E.J., 2000. Beta2-adrenoceptor agonists suppresses tumour necrosis factor production in rat mesangial cells. Cytokine, 12, 491-494
29. Opal, S.M. and DePalo, V.A., 2000. Anti-inflammatory cytokines. Chest, 117, 1162-1172
30. Pang, L. and Knox, A.J., 2000. Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells. American Journal of Respiratory Cell and Molecular Biology, 23, 79-85
31. Pirie, R.S., Collie, D.D., Dixon, P.M. and McGorum, B.C., 2002. Evaluation of nebulised hay dust suspensions (HDS) for the diagnosis and investigation of heaves. 2: Effects of inhaled HDS on control and heaves horses. Equine Veterinary Journal, 34, 337-342
32. Pirie, R.S., Dixon, P.M., Collie, D.D. and McGorum, B.C., 2001. Pulmonary and systemic effects of inhaled endotoxin in control and heaves horses. Equine Veterinary Journal, 33, 311-318
33. Reid, D.W., Ward, C., Wang, N., Zheng, L., Bish, R., Orsida, B. and Walters, E.H., 2003 Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo. European Respiratory Journal, 21, 994-999
34. Robinson, N.E., 2001. International Workshop on Equine Chronic Airway Disease. Michigan State University, 16-18 June 2000. Equine Veterinary Journal, 33, 5-19
35. Roilides, E., Uhlig, K., Venzon, D., Pizzo, P.A. and Walsh, T.J., 1993. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infection and Immunity, 61, 1185-1193
36. Sherwood, E.R., Varma, T.K., Fram, R.Y., Lin, C.Y., Koutrouvelis, A.P. and Toliver-Kinsky, T.E., 2001. Glucan phosphate potentiates endotoxin-induced interferon-gamma expression in immunocompetent mice, but attenuates induction of endotoxin tolerance. Clinical Science (London), 101, 541-550
37. Spoelstra, F.M., Postma, D.S., Hovenga, H., Noordhoek, J.A. and Kauffman, H.F., 2002. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts. Thorax, 57, 237-241
38. Strieter, R.M., Belperio, J.A. and Keane, M.P., 2003. Host innate defenses in the lung: The role of cytokines. Current Opinion in Infectious Disease, 16, 193-198
39. Walsh, G.M., Sexton, D.W., and Blaylock, M.G., 2003. Corticosteroids, eosinophils and bronchial epithelial cells: New insights into the resolution of inflammation in asthma. Journal of Endocrinology, 178, 37-43
40. Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X.F. and Achong, M.K., 1998. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. Journal of Clinical Investigation, 101, 311-320
41. Ye, R.D., 2000. β-Adrenergic agonists regulate NF-κB activation through multiple mechanisms. American Journal of Physiology. Lung Cellular and Molecular Physiology, 279, L615-617